HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.

AuthorsOliver A Cornely, Rafael F Duarte, Shariq Haider, Pranatharthi Chandrasekar, David Helfgott, Javier López Jiménez, Anna Candoni, Issam Raad, Michel Laverdiere, Amelia Langston, Nicholas Kartsonis, Marlou Van Iersel, Nancy Connelly, Hetty Waskin
JournalThe Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 71 Issue 6 Pg. 1747 (06 2016) ISSN: 1460-2091 [Electronic] England
PMID26960721 (Publication Type: Journal Article, Published Erratum)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: